Showing results (91-100 of 150) with videos related to
Sort By:
Pageof 15
Virchows Archiv : an International Journal of Pathology|June 2, 2014
FGFR3 mutations, but not FGFR3 expression and FGFR3 copy-number variations, are associated with favourable non-muscle invasive bladder cancerYann Neuzillet, Bas W G van Rhijn, Nadia L Prigoda, et al.BJU International|May 15, 2014
Prostate cancer incidence on cystoprostatectomy specimens is directly linked to age: results from a multicentre studyGéraldine Pignot, Laurent Salomon, Cédric Lebacle, et al.Cancers|December 10, 2021
Oncologic Impact and Safety of Pre-Operative Radiotherapy in Localized Prostate and Bladder Cancer: A Comprehensive Review from the Cancerology Committee of the Association Française d'UrologiePaul Sargos, Stéphane Supiot, Gilles Créhange, et al.The French Journal of Urology|October 18, 2025
French recommendations from the AFU Cancer Committee for prostate cancer: 2025 summary of changesGuillaume Ploussard, Michaël Baboudjian, Eric Barret, et al.The French Journal of Urology|June 26, 2026
Shifting Risk Profile in Radical Prostatectomy Over 18 Years: A Bicentric French Study of 8,358 PatientsYann Neuzillet, Joao Paulo Barbosa De Oliveira, François Rozet, et al.World Journal of Urology|July 16, 2020
PD-L1 expression and pattern of immune cells in pre-treatment specimens are associated with disease-free survival for HR-NMIBC undergoing BCG treatmentMathieu Roumiguié, Eva Compérat, Léonor Chaltiel, et al.Virchows Archiv : an International Journal of Pathology|February 21, 2015
Clinicopathological characteristics of urothelial bladder cancer in patients less than 40 years oldEva Compérat, Stéphane Larré, Morgan Roupret, et al.The French Journal of Urology|April 17, 2026
Guidelines from the cancer (CCAFU) and infection disease (CI-AFU) committees of the French association of Urology for the management of adverse events and complications of BCGPriscilla Leon, Laura I Levi, Thibaut Long Depaquit, et al.BJU International|January 22, 2013
Positive surgical margins and their locations in specimens are adverse prognosis features after radical cystectomy in non-metastatic carcinoma invading bladder muscle: results from a nationwide case-control studyYann Neuzillet, Michel Soulie, Stéphane Larre, et al.European Urology Oncology|August 29, 2024
Final Results of the ANDROCAN Study: Histopathological Characteristics and Biochemical Recurrence at 5 Years of Localized Prostate Cancer According to Preoperative Gonadal StatusYann Neuzillet, Jean-Pierre Raynaud, Jean-François Dreyfus, et al.Pageof 15